Chronic Pulmonary Aspergillosis Cpa clinical trials

Explore recruiting chronic pulmonary aspergillosis cpa clinical trials.

Recruiting chronic pulmonary aspergillosis cpa studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Pulmonary Aspergillosis Cpa trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase 2, multicentre, open-label, single arm study to evaluate the effectiveness and safety of rezafungin (as acetate) in the treatment of chronic pulmonary aspergillosis (CPA) in patients with limited treatment options

Hungary, Belgium, Austria, Germany, Netherlands, Italy +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Chronic Pulmonary Aspergillosis Cpa trials by city

Chronic Pulmonary Aspergillosis Cpa clinical trials

Recruiting chronic pulmonary aspergillosis cpa studies right now

Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome

A Trial to Compare Nebulized Amphotericin B and Nebulized Normal Saline as Maintenance in Patients With Chronic Pulmonary Aspergillosis

Also recruiting in Europe

A phase 2, multicentre, open-label, single arm study to evaluate the effectiveness and safety of rezafungin (as acetate) in the treatment of chronic pulmonary aspergillosis (CPA) in patients with limited treatment options

Chronic Pulmonary Aspergillosis Cpa trials by city

Other conditions